Using microbiomes as microsensors to forecast toxic algae blooms
使用微生物组作为微传感器来预测有毒藻类的繁殖
基本信息
- 批准号:10619616
- 负责人:
- 金额:$ 15.62万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-10 至 2025-04-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAgonistAgreementAlgaeAlgal BloomsArchivesBehaviorBiologicalBiological AssayBiological MarkersBiological ModelsCellsCessation of lifeChemicalsChemistryCircadian RhythmsCollectionCommunitiesCuesCytolysisDataData SetDermatitisDevelopmentDiatomsDockingEarly DiagnosisEcosystemEnvironmentEtiologyExhibitsExposure toFiltrationGlutamate ReceptorGoalsGrantHealthHealth Care CostsHourHumanIn SituIngestionKnowledgeLettersLightLinkLocationMass Spectrum AnalysisMetabolicMetabolismMethodsModelingMolecularMolecular ProfilingMonitorMunicipalitiesOceansOutcomeParalysedPatternPeptidesPeriodicityPhasePlaguePoisonPopulationPrivatizationProcessProductionPropertyProteinsPublic HealthReactionResolutionRespiratory Signs and SymptomsSamplingSeriesSignal TransductionSiteSurveysSystemTechnologyTestingTimeToxic effectToxinTranslatingValidationWaterWorkWorld Healthassay developmentbiomarker developmentbiomarker identificationchemical stabilitycircadiandesigndetection assaydetection platformdomoic acideconomic impactexposed human populationfood preparationharmful algal bloomsinnovationinsightmarinemetabolomicsmetaproteomicsmicrobial communitymicrobiomemicrosensormolecular markermolecular phenotypenovelnovel markerpreventrapid testremediationresponsesample collectionsuccesstemporal measurementtime usetooltoxic algaetoxic bloomtribal leaderwater qualitywater treatmentwaterborne
项目摘要
Project Summary
Harmful algal blooms (HABs) are becoming one of the greatest coastal and inland water quality threats to
public health. They last longer, occur more frequently and produce a wider range of toxic chemicals that
negatively impact human health than in past decades, yet we cannot forecast when an algal population will
bloom or produce toxins. As avoidance is the only public health strategy, there is a critical need to 1) develop
early warning detection systems to inform the public before (>24 hours) a harmful algae bloom, and 2) identify
chemical or physical cues in the water column that forecast HAB initiation for eventual biomarker development.
Co-occurring marine microbial communities (i.e., the microbiome) respond to light-driven circadian rhythms
of local photosynthetic algal populations and changes in water chemistry. This results in a detectable shift in
the microbiome’s expressed functions (i.e., molecular phenotype) that correlate to algal behavior and chemical
perturbations. We hypothesize that the time-dependent, molecular phenotype of the microbiome responds to
environmental perturbations that precede a toxic algal bloom, providing early detection of HAB formation.
The overall objective for this project is to track a) peptides expressed by the microbiome, and b) waterborne
metabolites associated with changing water chemistry in Eastsound, WA, the only known location that has
predictably timed HABs twice every year. No other HABs can currently be spatially or temporally predicted
even within a 1 to 2-week window. To capture the microbiome’s molecular signature of pre-bloom conditions,
we will conduct two field collections in year 1 timed to precede bloom initiation. For the next year only, we have
been granted 24hr access to a private dock in Eastsound, enabling the first-ever pre-bloom sample collection
to understand HAB formation. Our established high-resolution environmental samplers will collect the
microbiome and surrounding water every 4 hrs. Since cells tightly regulate protein abundance, changes in
protein levels associated with circadian patterns can be systematically quantified using novel mass
spectrometry-based peptide analyses. We will assess >20,000 peptides and test for rhythmicity and the loss
thereof, revealing critical timepoints that precede HAB formation and indicate a significant change in the local
water or physical conditions. Using the timing knowledge gained, we will then quantify metabolites in those,
and adjacent, archived timepoints using untargeted mass spectrometric metabolomics, connecting modulations
in peptide rhythmicity directly to microbiome metabolism and their chemical cues. The major outcome of the
proposed work will be the identification of peptide and metabolite biomarkers that precede HAB formation and
a fundamental understanding of chemical controls on bloom formation and toxin production. Our long-term goal
is to develop a rapid molecular assay that detects the identified changes in 1) the functionality of the water
microbiome and/or 2) crucial waterborne metabolites in advance of harmful algal bloom formation, in order to
prevent human exposure to bloom toxins, thereby protecting human health.
项目总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Brook Leanne Nunn其他文献
Brook Leanne Nunn的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
Agonist-GPR119-Gs复合物的结构生物学研究
- 批准号:32000851
- 批准年份:2020
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
相似海外基金
S1PR1 agonistによる脳血液関門制御を介した脳梗塞の新規治療法開発
S1PR1激动剂调节血脑屏障治疗脑梗塞新方法的开发
- 批准号:
24K12256 - 财政年份:2024
- 资助金额:
$ 15.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
AHR agonistによるSLE皮疹の新たな治療薬の開発
使用 AHR 激动剂开发治疗 SLE 皮疹的新疗法
- 批准号:
24K19176 - 财政年份:2024
- 资助金额:
$ 15.62万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 15.62万 - 项目类别:
AUGMENTING THE QUALITY AND DURATION OF THE IMMUNE RESPONSE WITH A NOVEL TLR2 AGONIST-ALUMINUM COMBINATION ADJUVANT
使用新型 TLR2 激动剂-铝组合佐剂增强免疫反应的质量和持续时间
- 批准号:
10933287 - 财政年份:2023
- 资助金额:
$ 15.62万 - 项目类别:
Targeting breast cancer microenvironment with small molecule agonist of relaxin receptor
用松弛素受体小分子激动剂靶向乳腺癌微环境
- 批准号:
10650593 - 财政年份:2023
- 资助金额:
$ 15.62万 - 项目类别:
AMPKa agonist in attenuating CPT1A inhibition and alcoholic chronic pancreatitis
AMPKa 激动剂减轻 CPT1A 抑制和酒精性慢性胰腺炎
- 批准号:
10649275 - 财政年份:2023
- 资助金额:
$ 15.62万 - 项目类别:
A randomized double-blind placebo controlled Phase 1 SAD study in male and female healthy volunteers to assess safety, pharmacokinetics, and transient biomarker changes by the ABCA1 agonist CS6253
在男性和女性健康志愿者中进行的一项随机双盲安慰剂对照 1 期 SAD 研究,旨在评估 ABCA1 激动剂 CS6253 的安全性、药代动力学和短暂生物标志物变化
- 批准号:
10734158 - 财政年份:2023
- 资助金额:
$ 15.62万 - 项目类别:
Investigating mechanisms underpinning outcomes in people on opioid agonist treatment for OUD: Disentangling sleep and circadian rhythm influences on craving and emotion regulation
研究阿片类激动剂治疗 OUD 患者结果的机制:解开睡眠和昼夜节律对渴望和情绪调节的影响
- 批准号:
10784209 - 财政年份:2023
- 资助金额:
$ 15.62万 - 项目类别:
A novel nanobody-based agonist-redirected checkpoint (ARC) molecule, aPD1-Fc-OX40L, for cancer immunotherapy
一种基于纳米抗体的新型激动剂重定向检查点 (ARC) 分子 aPD1-Fc-OX40L,用于癌症免疫治疗
- 批准号:
10580259 - 财政年份:2023
- 资助金额:
$ 15.62万 - 项目类别:
Identification and characterization of a plant growth promoter from wild plants: is this a novel plant hormone agonist?
野生植物中植物生长促进剂的鉴定和表征:这是一种新型植物激素激动剂吗?
- 批准号:
23K05057 - 财政年份:2023
- 资助金额:
$ 15.62万 - 项目类别:
Grant-in-Aid for Scientific Research (C)














{{item.name}}会员




